v3.26.1
Recapitalization (Tables)
 12 Months Ended
Dec. 31, 2025
Recapitalization [Abstract]  
Schedule of Business Combination The following table reconciles the elements of the Business Combination to the consolidated statement of cash flows and the consolidated statement of changes in stockholders’ deficit for the year ended December 31, 2025:
Cash - trust and cash, net of redemptions  $306,895 
Less: transaction costs, paid   (293,631)
Net proceeds from the Business Combination   13,264 
      
Less: accounts payable, accrued liabilities and other current liabilities combined   (3,013,837)
Less: Convertible notes payable combined   (770,000)
Less: Warrants liabilities combined   (230,000)
Reverse recapitalization, net  $(4,000,573)
Schedule of Ordinary Shares Issued Immediately Following the Consummation

The number of Class A ordinary shares issued immediately following the consummation of the Business Combination were:

 

PC4 Class A common stock, outstanding prior to the Business Combination   9,057,927 
Less: Redemption of PC4 Class A common stock   (307,742)
Class A common stock of PC4   8,750,185 
PC4 Class B common stock, outstanding prior to the Business Combination   1 
Business Combination Class A ordinary shares   8,750,186 
Issuance of shares related to preference shares conversion   12,185,000 
Issuance of shares related to working capital agreements   432,891 
BC2 Shares   11,450,000 
Class A ordinary shares immediately after the Business Combination   32,818,077 
Schedule of BC2 Shares was Determined

The number of BC2 shares was determined as follows:

 

       BC2’s shares
after		 
   BC2 Shares   conversion
ratio		 
Class A ordinary shares issued to existing BC2 Shareholders   127,361,990    11,450,000 
    127,361,990    11,450,000